FLUIDITI
LIVE

Serial Number

98864807

Owner

Bodyport Inc.

Attorney

Mark A. Jansen

Filing Date

Nov 21, 2024

Add to watchlist:

No watchlists yet
View on USPTO

FLUIDITI Trademark

Serial Number: 98864807

FLUIDITI is a trademark filed by Bodyport Inc. on November 21, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Bodyport Inc.

970 Folsom St.
San Francisco, CA 94017

Entity Type: 03

Trademark Details

Filing Date

November 21, 2024

Registration Date

Not Registered

Goods & Services

Providing temporary use of non-downloadable software; Providing temporary use of non-downloadable software for measuring, collecting, viewing, and analyzing health-related data in the field of chronic disease management; Providing temporary use of non-downloadable software for measuring, collecting, viewing, and analyzing health-related data in the field of heart disease; Providing temporary use of non-downloadable software for measuring, collecting, viewing, and analyzing health-related data in the field of kidney disease; Providing temporary use of non-downloadable software for remote management of body weight; Software as a service (SAAS); Platform as a service (PAAS); Software as a service (SAAS) featuring software for measuring, collecting, viewing, and analyzing health-related data in the field of chronic disease management; Software as a service (SAAS) featuring software for measuring, collecting, viewing, and analyzing health-related data in the field of heart disease; Software as a service (SAAS) featuring software for measuring, collecting, viewing, and analyzing health-related data in the field of kidney disease; Software as a service (SAAS) featuring software for remote management of chronic diseases; Software as a service (SAAS) featuring software for remote management of heart disease and heart failure; Software as a service (SAAS) featuring software for remote management of kidney disease; Providing temporary use of non-downloadable software for data analysis in the fields of biomarker information services, disease diagnosis, and efficacy of treatment predictions; Software as a service (SAAS) featuring software for data analysis in the fields of biomarker information services, disease diagnosis, and efficacy of treatment predictions; Providing temporary use of non-downloadable software for physicians to onboard patients, and track, view, and monitor health-related data of patients; Software as a service (SAAS) featuring software for physicians to onboard patients, and track, view, and monitor their health-related data; Providing temporary use of non-downloadable analytics computer software for physicians to onboard patients, and track, view, and monitor their health-related data in the field of chronic disease management; Providing temporary use of non-downloadable analytics computer software for physicians to onboard patients, and track, view, and monitor their health-related data in the field of heart disease; Providing temporary use of non-downloadable analytics computer software for physicians to onboard patients, and track, view, and monitor their health-related data in the field of kidney disease; Software as a service (SAAS) featuring analytics computer software for physicians to onboard patients, and track, view, and monitor health-related data of patients in the field of chronic disease management; Software as a service (SAAS) featuring analytics computer software for physicians to onboard patients, and track, view, and monitor health-related data of patients in the field of heart disease; Software as a service (SAAS) featuring analytics computer software for physicians to onboard patients, and track, view, and monitor health-related data of patients in the field of kidney disease; Providing temporary use of non-downloadable software in the nature of a portal for patients to access and view educational information and content; Providing temporary use of non-downloadable software in the nature of a portal for patients to access and view educational medical and health-related information and content in the field of chronic disease management; Providing temporary use of non-downloadable software in the nature of a portal for patients to access and view educational medical and health-related information and content in the field of heart disease; Providing temporary use of non-downloadable software in the nature of a portal for patients to access and view educational medical and health-related information and content in the field of kidney disease; Providing temporary use of online non-downloadable software for healthcare professionals

Software; Downloadable software; Downloadable software for measuring, collecting, viewing, and analyzing health-related data in the field of chronic disease management; Downloadable software for measuring, collecting, viewing, and analyzing health-related data in the field of heart disease; Downloadable software for measuring, collecting, viewing, and analyzing health-related data in the field of kidney disease; Downloadable software for remote management of body weight; remote management of body weight; Downloadable software for remote management of chronic diseases; Downloadable software for remote management of heart disease and heart failure; Downloadable software for remote management of kidney disease; Downloadable software for data analysis in the fields of biomarker information services, disease diagnosis, and efficacy of treatment predictions; Downloadable software for physicians to onboard patients, and track, view, and monitor health-related data of patients; Downloadable software for physicians to onboard patients, and track, view, and monitor health-related data of patients in the field of chronic disease management; Downloadable software for physicians to onboard patients, and track, view, and monitor health-related data of patients in the field of heart disease; Downloadable software for physicians to onboard patients, and track, view, and monitor health-related data of patients in the field of kidney disease; Downloadable software in the nature of a portal for patients to access and view educational information and content; Downloadable software in the nature of a portal for patients to access and view educational medical and health-related information and content in the field of chronic disease management; Downloadable software in the nature of a portal for patients to access and view educational medical and health-related information and content in the field of heart disease; Downloadable software in the nature of a portal for patients to access and view educational medical and health-related information and content in the field of kidney disease; Downloadable software for healthcare professionals; Computer hardware; Computer peripherals

Medical devices; Medical devices for measuring, collecting, and analyzing medical data; Medical devices for managing medical data; Medical devices for assessing, monitoring, and improving cardiac performance and tracking body weight; Medical devices for remote management of chronic diseases and tracking body weight; Medical devices for remote management of heart disease and heart failure; Medical devices for remote management of kidney disease; Medical devices, namely, sensors and scales; Medical devices, namely, sensors and scales for managing medical data; Medical devices, namely, sensors and scales for measuring, collecting, and analyzing medical data; Medical devices, namely sensors and scales for assessing, monitoring, and improving cardiac performance and tracking body weight; Medical devices, namely sensors and scales for remote management of chronic diseases and tracking body weight; Medical devices, namely sensors and scales for remote management of heart disease and heart failure; Medical devices, namely sensors and scales for remote management of kidney disease

Filing History

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 10, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 10, 2026 GNSL
SUSPENSION LETTER WRITTEN
Apr 10, 2026 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 11, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 11, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 11, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 28, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 28, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 11, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jun 11, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jun 11, 2025 CNRT
ASSIGNED TO EXAMINER
May 14, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 26, 2025 NWOS
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Dec 3, 2024 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Dec 3, 2024 PARI
NEW APPLICATION ENTERED
Nov 21, 2024 NWAP